Island Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Island Pharmaceuticals has a total shareholder equity of A$1.5M and total debt of A$422.0K, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are A$2.6M and A$1.0M respectively.
Key information
27.8%
Debt to equity ratio
AU$421.97k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$1.66m |
| Equity | AU$1.52m |
| Total liabilities | AU$1.05m |
| Total assets | AU$2.56m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ILA's short term assets (A$2.6M) exceed its short term liabilities (A$1.0M).
Long Term Liabilities: ILA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ILA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ILA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ILA has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ILA is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.